Research graph
References from Eosinophils in bronchiectasis. Local targets link to admitted publications; unresolved targets remain external evidence.
The precision medicine era of bronchiectasis
10.1164/rccm.202403-0473pp · 2024 · External reference
Characterization of eosinophilic bronchiectasis: a European multicohort study
10.1164/rccm.202108-1889oc · 2022 · External reference
Inflammation: a two-edged sword--the model of bronchiectasis
1986 · External reference
Advances in bronchiectasis: endotyping, genetics, microbiome, and disease heterogeneity
10.1016/s0140-6736(18)31767-7 · 2018 · External reference
Infection vs inflammation
10.1016/j.chest.2024.06.002 · 2024 · External reference
Neutrophil-derived proteases in lung inflammation: old players and new prospects
10.3390/ijms25105492 · 2024 · External reference
Neutrophilic inflammation in bronchiectasis
10.1183/16000617.0179-2024 · 2025 · External reference
Brensocatib in patients with bronchiectasis: subgroup analyses from the WILLOW trial
10.1183/23120541.00505-2024 · 2025 · External reference
Phase 3 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis
10.1056/nejmoa2411664 · 2025 · External reference
Efficacy of brensocatib in patients with eosinophilic bronchiectasis: an analysis of the ASPEN Trial
10.1164/ajrccm.2025.211.abstracts.a5239 · 2025 · External reference
Clinical, molecular and microbial characterisation of the eosinophilic endotype of bronchiectasis: data from the EMBARC-BRIDGE study
10.1136/thorax-2025-223305 · 2026 · External reference
Inflammatory molecular endotypes in bronchiectasis: a European Multicenter Cohort Study
10.1164/rccm.202303-0499oc · 2023 · External reference
The role of noninvasive modalities for assessing inflammation in patients with noncystic fibrosis bronchiectasis
10.1016/j.cyto.2017.08.005 · 2017 · External reference
Significance and potential role of eosinophils in non-cystic fibrosis bronchiectasis
10.1016/j.jaip.2022.10.027 · 2023 · External reference
Eosinophil cationic protein (ECP) polymorphisms and association with asthma, s-ECP levels and related phenotypes
10.1111/j.1398-9995.2007.01327.x · 2007 · External reference
Antibacterial properties of eosinophil major basic protein and eosinophil cationic protein
10.4049/jimmunol.142.12.4428 · 1989 · External reference
Identification of elastase in human eosinophils: Immunolocalization, isolation, and partial characterization
10.1016/0003-9861(92)90060-a · 1992 · External reference
How to detect eosinophil ETosis (EETosis) and extracellular traps
10.1016/j.alit.2020.10.002 · 2021 · External reference
Tissue eosinophilia and eosinophil degranulation in syndromes associated with fibrosis
1992 · External reference
Eosinophil-derived cationic proteins activate the synthesis of remodeling factors by airway epithelial cells
10.4049/jimmunol.177.7.4861 · 2006 · External reference
Eosinophil-derived exosomes contribute to asthma remodelling by activating structural lung cells
10.1111/cea.13122 · 2018 · External reference
Eosinophil extracellular traps drive asthma progression through neuro-immune signals
10.1038/s41556-021-00762-2 · 2021 · External reference
Mucus plugs in patients with asthma linked to eosinophilia and airflow obstruction
10.1172/jci95693 · 2018 · External reference
Repeatability of Circulating Eosinophil Measures and Inhaled Corticosteroids Effect in Bronchiectasis. A Post Hoc Analysis of a Randomized Clinical Trial
10.1016/j.arbres.2020.06.005 · 2020 · External reference
Eosinophilic bronchiectasis: prevalence, severity, and associated features—a cohort study
10.3390/jcm13164932 · 2024 · External reference
Association of blood total immunoglobulin E and eosinophils with radiological features of bronchiectasis
10.1186/s12890-023-02607-0 · 2023 · External reference
T2-high endotype and response to biological treatments in patients with bronchiectasis
10.3390/biomedicines9070772 · 2021 · External reference
Evidence for eosinophil activation in bronchiectasis unrelated to cystic fibrosis and bronchopulmonary aspergillosis: discrepancy between blood eosinophil counts and serum eosinophil cationic protein levels
10.1136/thx.53.6.498 · 1998 · External reference
Elevated eosinophil counts in acute exacerbations of bronchiectasis: unveiling a distinct clinical phenotype
10.1007/s00408-023-00668-w · 2024 · External reference
The U-shaped relationship between eosinophil count and bronchiectasis severity
10.1016/j.chest.2023.04.029 · 2023 · External reference
Blood Eosinophil Counts in Clinical Trials for Chronic Obstructive Pulmonary Disease
10.1164/rccm.201912-2384pp · 2020 · External reference
Muco-obstructive lung diseases
10.1056/nejmra1813799 · 2019 · External reference
A comprehensive approach to lung function in bronchiectasis
10.1016/j.rmed.2018.10.031 · 2018 · External reference
Prevalence of asthma, atopy, and bronchial hyperreactivity in bronchiectasis: a controlled study
10.1136/thx.44.11.948 · 1989 · External reference
Uncomplicated asthma in adults: comparison of CT appearance of the lungs in asthmatic and healthy subjects
10.1148/radiology.188.3.8351357 · 1993 · External reference
Persistent asthma in adults: comparison of high resolution computed tomography of the lungs after one year of follow-up
10.1590/s0041-87812001000300001 · 2001 · External reference
An analysis of etiology, causal pathogens, imaging patterns, and treatment of Japanese patients with bronchiectasis
10.1016/j.resinv.2014.09.004 · 2015 · External reference
Asthma and bronchiectasis exacerbation
10.1183/13993003.01862-2015 · 2016 · External reference
Links between hospital diagnoses of bronchiectasis and asthma
10.1111/j.1398-9995.1997.tb00186.x · 1997 · External reference
Adult patients with bronchiectasis
10.1016/j.chest.2016.10.055 · 2017 · External reference
Bronchiectasis and asthma: data from the European Bronchiectasis Registry (EMBARC)
10.1016/j.jaci.2024.01.027 · 2024 · External reference
The link between asthma and bronchiectasis: state of the art
10.1159/000507228 · 2020 · External reference
Clinical features of asthma with comorbid bronchiectasis: a systematic review and meta-analysis
10.1097/md.0000000000023858 · 2021 · External reference
How does comorbid bronchiectasis affect asthmatic patients? A meta-analysis
10.1080/02770903.2020.1784194 · 2021 · External reference
Computed tomography of the lungs in asthma: influence of disease severity and etiology
10.1164/ajrccm.153.1.8542102 · 1996 · External reference
A morphologic study of the airway structure abnormalities in patients with asthma by high-resolution computed tomography
10.21037/jtd.2016.09.36 · 2016 · External reference
Factors associated with bronchiectasis in patients with uncontrolled asthma; the NOPES score: a study in 398 patients
10.1186/s12931-018-0746-7 · 2018 · External reference
Bronchial dilatation in asthma
10.1378/chest.125.4.1352 · 2004 · External reference
Impact of asthma on bronchiectasis severity and risk of exacerbations
10.1080/02770903.2020.1857395 · 2022 · External reference
Bronchiectasis in severe asthma
10.1016/j.anai.2018.02.016 · 2018 · External reference
Bronchiectasis and increased mortality in patients with corticosteroid-dependent severe asthma: a nationwide population study
10.1177/1753466620963030 · 2020 · External reference
Severe asthma and bronchiectasis
10.1080/02770903.2019.1579832 · 2020 · External reference
Revised ISHAM-ABPA working group clinical practice guidelines for diagnosing, classifying and treating allergic bronchopulmonary aspergillosis/mycoses
10.1183/13993003.00061-2024 · 2024 · External reference
Allergic bronchopulmonary aspergillosis and Aspergillus-related airway diseases in bronchiectasis: a narrative review
10.21037/jtd-2025-1548 · 2025 · External reference
Clinical and immunological characteristics of Aspergillus fumigatus-sensitized asthma and allergic bronchopulmonary aspergillosis
10.3389/fimmu.2022.939127 · 2022 · External reference
Clinical relevance of peripheral blood eosinophil count in allergic bronchopulmonary aspergillosis
10.1016/j.jiph.2011.08.006 · 2011 · External reference
Th2-skewed peripheral T-helper cells drive B-cells in allergic bronchopulmonary aspergillosis
10.1183/13993003.00386-2024 · 2024 · External reference
A randomised trial of prednisolone versus prednisolone and itraconazole in acute-stage allergic bronchopulmonary aspergillosis complicating asthma
10.1183/13993003.01787-2021 · 2022 · External reference
Evaluation of the drug–drug interaction between triazole antifungals and cystic fibrosis transmembrane conductance regulator modulators in a real-life cohort
10.1093/mmy/myae020 · 2024 · External reference
Serum eosinophil cationic protein, eosinophil protein X and eosinophil peroxidase in relation to pulmonary function in cystic fibrosis
10.1046/j.1365-2222.1998.00216.x · 1998 · External reference
Increased degranulation of eosinophil and neutrophil granulocytes in cystic fibrosis
10.1164/ajrccm.152.2.7633718 · 1995 · External reference
Cytokine concentrations in sputum from patients with cystic fibrosis and their relation to eosinophil activity
1997 · External reference
Association between elevated peripheral blood eosinophil count and respiratory outcomes in adults with cystic fibrosis
10.1016/j.jcf.2022.03.009 · 2022 · External reference
Association between Cystic Fibrosis exacerbations, lung function, T2 inflammation and microbiological colonization
10.1186/s13223-023-00760-z · 2023 · External reference
Type 2 inflammation in cystic fibrosis is a predictor of mortality and targeted with CFTR modulator therapy
10.1111/all.16198 · 2024 · External reference
Cystic Fibrosis Pulmonary Guidelines
10.1164/rccm.201207-1160oe · 2013 · External reference
European Respiratory Society clinical practice guideline for the management of adult bronchiectasis
10.1183/13993003.01126-2025 · 2025 · External reference
Use of inhaled corticosteroids in bronchiectasis: data from the European Bronchiectasis Registry (EMBARC)
10.1136/thorax-2024-221825 · 2025 · External reference
Comparative risks of chronic inhaled corticosteroids and macrolides for bronchiectasis
10.1183/13993003.01896-2018 · 2019 · External reference
The U-shaped relationship between eosinophil count and bronchiectasis severity
10.1016/j.chest.2023.04.029 · 2023 · External reference
Role of inhaled corticosteroids in reducing exacerbations in bronchiectasis patients with blood eosinophilia pooled posthoc analysis of 2 randomized clinical trials
10.1016/j.rmed.2020.106127 · 2020 · External reference
Blood eosinophils predict inhaled fluticasone response in bronchiectasis
10.1183/13993003.00453-2020 · 2020 · External reference
Benralizumab in bronchiectasis: results from the phase 3 MAHALE study
10.1183/23120541.01529-2025 · 2026 · External reference
Clinical efficacy and immunologic effects of omalizumab in allergic bronchopulmonary aspergillosis
2015 · External reference
Dupilumab improves lung function and reduces total and specific IgE levels in patients with asthma and allergic bronchopulmonary aspergillosis: the phase 2 LIBERTY ABPA AIRED Study
10.1016/j.jaci.2025.12.834 · 2026 · External reference
Use of monoclonal antibodies for allergic bronchopulmonary aspergillosis in patients with asthma and cystic fibrosis: literature review
10.1177/1753466620961648 · 2020 · External reference
Efficacy of biologics in patients with allergic bronchopulmonary aspergillosis: a systematic review and meta-analysis
10.1007/s00408-024-00717-y · 2024 · External reference
Treatment of allergic bronchopulmonary aspergillosis with biologics
10.1016/j.pccm.2024.11.005 · 2025 · External reference
Biologic drugs in treating allergic bronchopulmonary aspergillosis in patients with cystic fibrosis: a systematic review
10.1183/16000617.0011-2022 · 2022 · External reference
Real-world effectiveness of biologic therapy in allergic bronchopulmonary aspergillosis
10.1016/j.jaip.2025.03.006 · 2025 · External reference
Mepolizumab as possible treatment for allergic bronchopulmonary aspergillosis: a review of eight cases
2020 · External reference
A multicenter retrospective study evaluating IL-5-targeted biologic therapies for the treatment of asthma and allergic bronchopulmonary aspergillosis in adults with cystic fibrosis
10.1016/j.chpulm.2025.100163 · 2025 · External reference
Omalizumab in Allergic Bronchopulmonary Aspergillosis: A Systematic Review and Meta-Analysis
10.1016/j.jaip.2022.12.012 · 2023 · External reference
Corticosteroid-sparing effect of biologics in patients with allergic bronchopulmonary aspergillosis
10.1016/j.anai.2024.01.010 · 2024 · External reference
Present and future of biological treatments in bronchiectasis
10.1016/j.opresp.2025.100473 · 2025 · External reference
Efficacy of type-2 targeted biologics in patients with asthma and bronchiectasis
10.1016/j.anai.2020.11.014 · 2021 · External reference
Elevated eosinophil counts in acute exacerbations of bronchiectasis: unveiling a distinct clinical phenotype
10.1007/s00408-023-00668-w · ExternalCitation · doi-reference
Efficacy of biologics in patients with allergic bronchopulmonary aspergillosis: a systematic review and meta-analysis
10.1007/s00408-024-00717-y · ExternalCitation · doi-reference
Identification of elastase in human eosinophils: Immunolocalization, isolation, and partial characterization
10.1016/0003-9861(92)90060-a · ExternalCitation · doi-reference
How to detect eosinophil ETosis (EETosis) and extracellular traps
10.1016/j.alit.2020.10.002 · ExternalCitation · doi-reference
Bronchiectasis in severe asthma
10.1016/j.anai.2018.02.016 · ExternalCitation · doi-reference
Efficacy of type-2 targeted biologics in patients with asthma and bronchiectasis
10.1016/j.anai.2020.11.014 · ExternalCitation · doi-reference
Corticosteroid-sparing effect of biologics in patients with allergic bronchopulmonary aspergillosis
10.1016/j.anai.2024.01.010 · ExternalCitation · doi-reference
Repeatability of Circulating Eosinophil Measures and Inhaled Corticosteroids Effect in Bronchiectasis. A Post Hoc Analysis of a Randomized Clinical Trial
10.1016/j.arbres.2020.06.005 · ExternalCitation · doi-reference
Adult patients with bronchiectasis
10.1016/j.chest.2016.10.055 · ExternalCitation · doi-reference
The U-shaped relationship between eosinophil count and bronchiectasis severity
10.1016/j.chest.2023.04.029 · ExternalCitation · doi-reference
Infection vs inflammation
10.1016/j.chest.2024.06.002 · ExternalCitation · doi-reference
A multicenter retrospective study evaluating IL-5-targeted biologic therapies for the treatment of asthma and allergic bronchopulmonary aspergillosis in adults with cystic fibrosis
10.1016/j.chpulm.2025.100163 · ExternalCitation · doi-reference
The role of noninvasive modalities for assessing inflammation in patients with noncystic fibrosis bronchiectasis
10.1016/j.cyto.2017.08.005 · ExternalCitation · doi-reference
Bronchiectasis and asthma: data from the European Bronchiectasis Registry (EMBARC)
10.1016/j.jaci.2024.01.027 · ExternalCitation · doi-reference
Dupilumab improves lung function and reduces total and specific IgE levels in patients with asthma and allergic bronchopulmonary aspergillosis: the phase 2 LIBERTY ABPA AIRED Study
10.1016/j.jaci.2025.12.834 · ExternalCitation · doi-reference
Significance and potential role of eosinophils in non-cystic fibrosis bronchiectasis
10.1016/j.jaip.2022.10.027 · ExternalCitation · doi-reference
Omalizumab in Allergic Bronchopulmonary Aspergillosis: A Systematic Review and Meta-Analysis
10.1016/j.jaip.2022.12.012 · ExternalCitation · doi-reference
Real-world effectiveness of biologic therapy in allergic bronchopulmonary aspergillosis
10.1016/j.jaip.2025.03.006 · ExternalCitation · doi-reference
Association between elevated peripheral blood eosinophil count and respiratory outcomes in adults with cystic fibrosis
10.1016/j.jcf.2022.03.009 · ExternalCitation · doi-reference
Clinical relevance of peripheral blood eosinophil count in allergic bronchopulmonary aspergillosis
10.1016/j.jiph.2011.08.006 · ExternalCitation · doi-reference
Present and future of biological treatments in bronchiectasis
10.1016/j.opresp.2025.100473 · ExternalCitation · doi-reference
Treatment of allergic bronchopulmonary aspergillosis with biologics
10.1016/j.pccm.2024.11.005 · ExternalCitation · doi-reference
An analysis of etiology, causal pathogens, imaging patterns, and treatment of Japanese patients with bronchiectasis
10.1016/j.resinv.2014.09.004 · ExternalCitation · doi-reference
A comprehensive approach to lung function in bronchiectasis
10.1016/j.rmed.2018.10.031 · ExternalCitation · doi-reference
Role of inhaled corticosteroids in reducing exacerbations in bronchiectasis patients with blood eosinophilia pooled posthoc analysis of 2 randomized clinical trials
10.1016/j.rmed.2020.106127 · ExternalCitation · doi-reference
Advances in bronchiectasis: endotyping, genetics, microbiome, and disease heterogeneity
10.1016/s0140-6736(18)31767-7 · ExternalCitation · doi-reference
Eosinophil extracellular traps drive asthma progression through neuro-immune signals
10.1038/s41556-021-00762-2 · ExternalCitation · doi-reference
Serum eosinophil cationic protein, eosinophil protein X and eosinophil peroxidase in relation to pulmonary function in cystic fibrosis
10.1046/j.1365-2222.1998.00216.x · ExternalCitation · doi-reference
Phase 3 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis
10.1056/nejmoa2411664 · ExternalCitation · doi-reference
Muco-obstructive lung diseases
10.1056/nejmra1813799 · ExternalCitation · doi-reference
Severe asthma and bronchiectasis
10.1080/02770903.2019.1579832 · ExternalCitation · doi-reference
How does comorbid bronchiectasis affect asthmatic patients? A meta-analysis
10.1080/02770903.2020.1784194 · ExternalCitation · doi-reference
Impact of asthma on bronchiectasis severity and risk of exacerbations
10.1080/02770903.2020.1857395 · ExternalCitation · doi-reference
Evaluation of the drug–drug interaction between triazole antifungals and cystic fibrosis transmembrane conductance regulator modulators in a real-life cohort
10.1093/mmy/myae020 · ExternalCitation · doi-reference
Clinical features of asthma with comorbid bronchiectasis: a systematic review and meta-analysis
10.1097/md.0000000000023858 · ExternalCitation · doi-reference
Type 2 inflammation in cystic fibrosis is a predictor of mortality and targeted with CFTR modulator therapy
10.1111/all.16198 · ExternalCitation · doi-reference
Eosinophil-derived exosomes contribute to asthma remodelling by activating structural lung cells
10.1111/cea.13122 · ExternalCitation · doi-reference
Links between hospital diagnoses of bronchiectasis and asthma
10.1111/j.1398-9995.1997.tb00186.x · ExternalCitation · doi-reference
Eosinophil cationic protein (ECP) polymorphisms and association with asthma, s-ECP levels and related phenotypes
10.1111/j.1398-9995.2007.01327.x · ExternalCitation · doi-reference
Use of inhaled corticosteroids in bronchiectasis: data from the European Bronchiectasis Registry (EMBARC)
10.1136/thorax-2024-221825 · ExternalCitation · doi-reference
Clinical, molecular and microbial characterisation of the eosinophilic endotype of bronchiectasis: data from the EMBARC-BRIDGE study
10.1136/thorax-2025-223305 · ExternalCitation · doi-reference
Prevalence of asthma, atopy, and bronchial hyperreactivity in bronchiectasis: a controlled study
10.1136/thx.44.11.948 · ExternalCitation · doi-reference
Evidence for eosinophil activation in bronchiectasis unrelated to cystic fibrosis and bronchopulmonary aspergillosis: discrepancy between blood eosinophil counts and serum eosinophil cationic protein levels
10.1136/thx.53.6.498 · ExternalCitation · doi-reference
Uncomplicated asthma in adults: comparison of CT appearance of the lungs in asthmatic and healthy subjects
10.1148/radiology.188.3.8351357 · ExternalCitation · doi-reference
The link between asthma and bronchiectasis: state of the art
10.1159/000507228 · ExternalCitation · doi-reference
Increased degranulation of eosinophil and neutrophil granulocytes in cystic fibrosis
10.1164/ajrccm.152.2.7633718 · ExternalCitation · doi-reference
Computed tomography of the lungs in asthma: influence of disease severity and etiology
10.1164/ajrccm.153.1.8542102 · ExternalCitation · doi-reference
Efficacy of brensocatib in patients with eosinophilic bronchiectasis: an analysis of the ASPEN Trial
10.1164/ajrccm.2025.211.abstracts.a5239 · ExternalCitation · doi-reference
Cystic Fibrosis Pulmonary Guidelines
10.1164/rccm.201207-1160oe · ExternalCitation · doi-reference
Blood Eosinophil Counts in Clinical Trials for Chronic Obstructive Pulmonary Disease
10.1164/rccm.201912-2384pp · ExternalCitation · doi-reference
Characterization of eosinophilic bronchiectasis: a European multicohort study
10.1164/rccm.202108-1889oc · ExternalCitation · doi-reference
Inflammatory molecular endotypes in bronchiectasis: a European Multicenter Cohort Study
10.1164/rccm.202303-0499oc · ExternalCitation · doi-reference
The precision medicine era of bronchiectasis
10.1164/rccm.202403-0473pp · ExternalCitation · doi-reference
Mucus plugs in patients with asthma linked to eosinophilia and airflow obstruction
10.1172/jci95693 · ExternalCitation · doi-reference
Use of monoclonal antibodies for allergic bronchopulmonary aspergillosis in patients with asthma and cystic fibrosis: literature review
10.1177/1753466620961648 · ExternalCitation · doi-reference
Bronchiectasis and increased mortality in patients with corticosteroid-dependent severe asthma: a nationwide population study
10.1177/1753466620963030 · ExternalCitation · doi-reference
Revised ISHAM-ABPA working group clinical practice guidelines for diagnosing, classifying and treating allergic bronchopulmonary aspergillosis/mycoses
10.1183/13993003.00061-2024 · ExternalCitation · doi-reference
Th2-skewed peripheral T-helper cells drive B-cells in allergic bronchopulmonary aspergillosis
10.1183/13993003.00386-2024 · ExternalCitation · doi-reference
Blood eosinophils predict inhaled fluticasone response in bronchiectasis
10.1183/13993003.00453-2020 · ExternalCitation · doi-reference
European Respiratory Society clinical practice guideline for the management of adult bronchiectasis
10.1183/13993003.01126-2025 · ExternalCitation · doi-reference
A randomised trial of prednisolone versus prednisolone and itraconazole in acute-stage allergic bronchopulmonary aspergillosis complicating asthma
10.1183/13993003.01787-2021 · ExternalCitation · doi-reference
Asthma and bronchiectasis exacerbation
10.1183/13993003.01862-2015 · ExternalCitation · doi-reference
Comparative risks of chronic inhaled corticosteroids and macrolides for bronchiectasis
10.1183/13993003.01896-2018 · ExternalCitation · doi-reference
Biologic drugs in treating allergic bronchopulmonary aspergillosis in patients with cystic fibrosis: a systematic review
10.1183/16000617.0011-2022 · ExternalCitation · doi-reference
Neutrophilic inflammation in bronchiectasis
10.1183/16000617.0179-2024 · ExternalCitation · doi-reference
Brensocatib in patients with bronchiectasis: subgroup analyses from the WILLOW trial
10.1183/23120541.00505-2024 · ExternalCitation · doi-reference
Benralizumab in bronchiectasis: results from the phase 3 MAHALE study
10.1183/23120541.01529-2025 · ExternalCitation · doi-reference
Association of blood total immunoglobulin E and eosinophils with radiological features of bronchiectasis
10.1186/s12890-023-02607-0 · ExternalCitation · doi-reference
Factors associated with bronchiectasis in patients with uncontrolled asthma; the NOPES score: a study in 398 patients
10.1186/s12931-018-0746-7 · ExternalCitation · doi-reference
Association between Cystic Fibrosis exacerbations, lung function, T2 inflammation and microbiological colonization
10.1186/s13223-023-00760-z · ExternalCitation · doi-reference
Bronchial dilatation in asthma
10.1378/chest.125.4.1352 · ExternalCitation · doi-reference
Persistent asthma in adults: comparison of high resolution computed tomography of the lungs after one year of follow-up
10.1590/s0041-87812001000300001 · ExternalCitation · doi-reference
Allergic bronchopulmonary aspergillosis and Aspergillus-related airway diseases in bronchiectasis: a narrative review
10.21037/jtd-2025-1548 · ExternalCitation · doi-reference
A morphologic study of the airway structure abnormalities in patients with asthma by high-resolution computed tomography
10.21037/jtd.2016.09.36 · ExternalCitation · doi-reference
Clinical and immunological characteristics of Aspergillus fumigatus-sensitized asthma and allergic bronchopulmonary aspergillosis
10.3389/fimmu.2022.939127 · ExternalCitation · doi-reference
T2-high endotype and response to biological treatments in patients with bronchiectasis
10.3390/biomedicines9070772 · ExternalCitation · doi-reference
Neutrophil-derived proteases in lung inflammation: old players and new prospects
10.3390/ijms25105492 · ExternalCitation · doi-reference
Eosinophilic bronchiectasis: prevalence, severity, and associated features—a cohort study
10.3390/jcm13164932 · ExternalCitation · doi-reference
Antibacterial properties of eosinophil major basic protein and eosinophil cationic protein
10.4049/jimmunol.142.12.4428 · ExternalCitation · doi-reference
Eosinophil-derived cationic proteins activate the synthesis of remodeling factors by airway epithelial cells
10.4049/jimmunol.177.7.4861 · ExternalCitation · doi-reference
